Interestingly, BMI-1 can be a target of graft-versus-leukemia (GVL) responses in patients with CML receiving HSCT from an HLA-identical sibling [80]. Here, BMI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.